Choose Site

In the News

Life Sciences Cases To Watch In 2014, Law360

January 01, 2014

Life Sciences partner Stephen Paul Mahinka comments on the FTC v. Cephalon, the FTC's challenge on pay-for-delay agreements restricting generic drug market entry.